Cagrilintide / Semaglutide Blend 5mg / 5mg

$45.00
Research profileView lab documentation
Peptides
Cagrilintide / Semaglutide
Amount
Cagrilintide 5 mg / Semaglutide 5 mg per vial
Form
Vial
Content
Cagrilintide: 4.63 mg; Semaglutide: 4.42 mgReport #216340 · Aug 11, 2026 · submitted sample
Fulfillment
Austin, Texas, USA
Storage
Follow the Cagrilintide / Semaglutide vial label and lot-specific storage instructions.
Short description
This research blend combines the amylin analogue cagrilintide and the GLP-1 receptor agonist semaglutide.

Product-specific label and lot instructions take precedence.

In stock · Fulfilled from Austin, TexasMost in-stock orders are usually processed within 1 business day after order review and payment approval.
Category:
RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE
Laboratory documentation

Janoshik reports & sample documentation

Original laboratory records for the submitted samples, with measured results and verification links.

Supplied analytical report

Content report

#216340

Cagrilintide
4.63mg
Semaglutide
4.42mg
Report identifiers
Laboratory
Janoshik
Task
216340
Verification key
VDTUICM6NAMS
Report batch
05042026C5
Laboratory sample label
CAGRILINTIDE / SEMAGLUTIDE Blend 5mg / 5mg
Testing ordered
Jul 31, 2026
Sample received
Aug 4, 2026
Tests requested
Cagrilintide/Semaglutide (CagriSema) blend analysis
Verify report on Janoshik (new tab)
Endotoxin report Aug 6, 2026 · #216341
Additional supplied test

Endotoxin report

#216341

Endotoxin
1.636 EU/Vial
Report identifiers
Laboratory
Janoshik
Task
216341
Verification key
WPMX4JMUKPV1
Report batch
05042026C5
Laboratory sample label
CAGRILINTIDE / SEMAGLUTIDE Blend 5mg / 5mg
Testing ordered
Jul 31, 2026
Sample received
Aug 4, 2026
Tests requested
Endotoxin Analysis
Verify report on Janoshik (new tab)
Research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.